The hallmarks of castration-resistant prostate cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The hallmarks of castration-resistant prostate cancers

Published:2015-07 Issue:7 Volume:41 Page:588-597
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Katsogiannou Maria,Ziouziou Hajer,Karaki Sara,Andrieu Claudia,Henry de Villeneuve Marie,Rocchi Palma

Funder

French Cancer Institute

ITMO Cancer

Institut national de la santé et de la recherche médicale

Association pour la Recherche sur le Cancer

Agence Nationale pour la Recherche

Aix-Marseille University and competitivity pole Eurobiomed

ARTP

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference167 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

3. Treatment options in hormone-refractory metastatic prostate carcinoma;Fusi;Tumori,2004

4. Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes;Galsky;CA Cancer J Clin,2012

5. The evolutionary history of lethal metastatic prostate cancer;Gundem;Nature,2015

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients;Journal of Translational Medicine;2024-06-27

2. Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8‐DNA interactions and effectively inhibits prostate tumor growth in mice;Molecular Oncology;2024-04-11

3. Microfluidics-Based Technologies for the Assessment of Castration-Resistant Prostate Cancer;Cells;2024-03-26

4. Discovery of Novel Inhibitors of BRD4 for Treating Prostate Cancer: A Comprehensive Case Study for Considering Water Networks in Virtual Screening and Drug Design;Journal of Medicinal Chemistry;2023-12-28

5. Cardiovascular Complications in Patients with Prostate Cancer: Potential Molecular Connections;International Journal of Molecular Sciences;2023-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3